Nongenomic glucocorticoid signaling: New targets for immunosuppressive therapy?
β Scribed by J. Leonard M. Schoneveld; Ruth D. Fritsch-Stork; Johannes W. J. Bijlsma
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 119 KB
- Volume
- 63
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract A better understanding of how schistosomes exploit host nutrients, neuroβendocrine hormones and signalling pathways for growth, development and maturation may provide new insights for improved interventions in the control of schistosomiasis. This paper describes recent advances in the i
In the above article, we -the authors -described recent advances in the identification and characterisation of schistosome tyrosine kinase and signalling pathways, notably the potential intervention value of insulin signalling in schistosomes. For greater completeness of relevant references, we woul
Coupling of photosensitizers to tumor-selective monoclonal antibodies (MAbs) is an attractive option for improving the selectivity of photodynamic therapy (PDT). For this purpose, hydrophilic sensitizers would be most suitable because of their solubility in water. However, such sensitizers are known